Programa

Coloquio: Tecnología, Ciencia y Cultura: una visión global

HORARIO	ACTIVIDAD
9:00 - 09:15 h	Inauguración Sala de Artes Escénicas
9:30 - 10:45 h	Plática Dr. Theo Lynn Dublin City University
10:45 - 11:15 h	«Coffee Break» Lobby BI-310 / Lobby Sala de Artes Escénicas
11:15 - 12:30 h	Plática Dr. Horacio Bach University of British Columbia
12:30 - 13:30 h	Evaluación de Posters Pasillo de la Biblioteca
13:30 - 15:30 h	COMIDA
15:45 - 17:00 h	Plática Dr. Andreas Linninger University of Illinois
17:00 - 17:15 h	«Coffee Break» Lobby BI-310 / Lobby Sala de Artes Escénicas
17:15 - 18:30 h	Plática Dr. Miguel Rico-Ramírez University of Bristol
18:45 - 19:00 h	Best Poster Award / Clausura Sala de Artes Escénicas

Regresar

Dr. Horacio Bach, Ph.D.

Ponente especial

"A NEW ERA WITHOUT ANTIBIOTICS"

Horacio Bach earned his PhD in Molecular Microbiology and Biotechnology from the University of Tel Aviv in 2001, studying the interactions between esterases and the polysaccharide emulsan. Subsequently, in his first post-doctorate, he joined the laboratory of Prof. David Sherman in Minnesota working on the development of a biochip for generation of novel antibiotic molecules and the roles of P450 proteins from Streptomyces coelicolor. Dr. Bach worked for Taro Pharmaceuticals in Tel Aviv and New York developing novel fermentation technologies and engineering organisms for the production of steroids. In 2004, Dr. Bach joined the laboratory of Prof. Yossef Av-Gay at the Division of Infectious Diseases, Department of Medicine, University of British Columbia in Vancouver, Canada. He worked on the function of tyrosine phosphatases of Mycobacterium tuberculosis and the interactions within the host macrophages. Currently, Dr. Bach holds an Adjunct Professor position at the same institution. His current research interests include: signal transduction, mechanism elucidation of virulence factors of pathogenic bacteria, the link between Mycobacterium paratuberculosis and inflammatory bowel diseases, the design of novel antibodies for therapeutics and diagnostic tests using antibody engineering, and applications of nanotechnology in Medicine. Prof. Bach is the author of over 70 publications, including papers, patents, and book chapters.

http://id.med.ubc.ca/person/horacio-bach/

• Adjunct Professor
• Manager of IIRC Proteomic and Antibody Engineering Facility
• University of British Columbia
• Division of Infectious Diseases
• Jack Bell Research Centre
• 410- 2660 Oak Street
• Vancouver BC V6H 3Z6, Canada
• Phone: 604 8754111x.62107
• Fax: 604 8754013

Regresar

Dr. Andreas Linninger

Ponente especial

Professor at University of Illinois at Chicago

Dr. Andreas Linninger is a Professor of Chemical Engineering at the University of Illinois at Chicago. Dr. Linninger is focused on fluid dynamics and micro-electronic device design. In his study, Molecular Intervention for Brain Water Regulation in Hydrocephalus, Dr. Linninger will use a novel microfluidic platform to quantify the amount and speed of water flux through aquaporin-4 channels, which are present in the brain and are involved in fluid regulation. This work will create the foundation to test drug interventions to increase fluid flow.

Regresar